18 F-Choline Images Murine Atherosclerotic Plaques Ex Vivo

Abstract
Objective— Current imaging modalities of atherosclerosis mainly visualize plaque morphology. Valuable insight into plaque biology was achieved by visualizing enhanced metabolism in plaque-derived macrophages using 18 F-fluorodeoxyglucose ( 18 F-FDG). Similarly, enhanced uptake of 18 F-fluorocholine ( 18 F-FCH) was associated with macrophages surrounding an abscess. As macrophages are important determinants of plaque vulnerability, we tested 18 F-FCH for plaque imaging. Methods and Results— We injected 18 F-FCH (n=5) or 18 F-FDG (n=5) intravenously into atherosclerotic apolipoprotein E-deficient mice. En face measurements of aortae isolated 20 minutes after 18 F-FCH injections demonstrated an excellent correlation between fat stainings and autoradiographies ( r =0.842, P 18 F-FCH. In contrast, radiotracer uptake 20 minutes after 18 F-FDG injections correlated less with en face fat stainings ( r =0.261, P 18 F-FCH and 14 C-FDG (n=3) showed that 18 F-FCH uptake correlated better with fat staining ( r =0.740, P r =0.740, P 14 C-FDG (fat: r =0.236, P =0.29 and CD68 staining: r =0.352, P =0.11), respectively. Conclusions— 18 F-FCH identifies murine plaques better than 18 F-FDG using ex vivo imaging. Enhanced 18 F-FCH uptake into macrophages may render this tracer a promising candidate for imaging plaques in patients.